Department Of Surgery

Vanderbilt-Ingram Cancer Center patient encourages early screening for colon cancer. Read More

Vanderbilt researchers have defined a mechanism that limits liver cell proliferation after injury in order to preserve critical metabolic functions. Read More

Carmen Solórzano, M.D., professor of Surgery and director of the Endocrine Surgery Center at Vanderbilt University Medical Center (VUMC), has been named chief of the Division of Surgical Oncology and Endocrine Surgery in the Department of Surgery. Read More

In a first-of-its-kind study of veterans and civilians, researchers from Vanderbilt University Medical Center found that one in 10 patients is at risk of having a new post-traumatic stress disorder (PTSD) following their time in the intensive care unit (ICU). Read More

Vanderbilt scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment. Read More

Douglas Hanto M.D., Ph.D., professor of Surgery and associate director of the Vanderbilt Transplant Center has been named the Center’s new director. His appointment becomes effective July 1. Read More

A team of Vanderbilt University Medical Center surgeons and biomedical engineers has developed a nanoparticle delivery system that may significantly improve the success rate of coronary artery bypass grafts. Read More

Seth Karp, M.D., professor of Surgery and Ingram Professor of Surgical Sciences, has been named the new chair of Vanderbilt’s Department of Surgery. Read More

Bill Nealon, M.D., professor of Surgery, associate Surgeon-in-Chief and associate executive Medical Director of Perioperative Services, is leaving Vanderbilt effective March 31. He’s been at Vanderbilt since 2009. Read More

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read More

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics. Read More

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain. Read More

Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation. Read More

A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies. Read More

Clostridium difficile on the intestinal lining. (Wellcome Images) Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read More

Each year, more than 350,000 people in the United States undergo surgery to treat painful ventral abdominal hernias, a condition that affects up to 30 percent of patients who have had any kind of abdominal surgery. Read More